A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients

Journal of Ethnopharmacology

Volumn 136, Issue 1, 2011, Pages 83-87

  Deng, Gary ^a   Kurtz, Robert C ^a   Vickers, Andrew ^a   Lau, Nancy ^b   Yeung, K Simon ^a   Shia, Jinru ^a   Cassileth, Barrie ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ST VINCENT S HOSPITAL   (United States)

Author keywords

Hepatitis C; Kampo medicine; Liver biopsy; Sho sai ko to; Traditional Chinese medicine; Xiao chai hu tang

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; XIAO CHAI HU TANG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; KNODELL HISTOLOGY ACTIVITY INDEX; LIVER BIOPSY; LIVER FUNCTION; MALE; MEDICAL PARAMETERS; OPEN STUDY; PHASE 2 CLINICAL TRIAL; PNEUMONIA; SINGLE BLIND PROCEDURE; VIRUS LOAD;

ALANINE TRANSAMINASE; ANGIOSPERMS; ASPARTATE AMINOTRANSFERASES; DRUGS, CHINESE HERBAL; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANTS, MEDICINAL; VIRAL LOAD;

HEPATITIS C VIRUS;

EID: 79958119860     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2011.04.008     Document Type: Article

References (43)

1. Alter, M.J., Seeff, L.B., Bacon, B.R., Thomas, D.L., Rigsby, M.O., Di Bisceglie, A.M., 2004. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Annals of Internal Medicine 141, 715-717. (Pubitemid 39434844)
2. Armstrong, G.L., Wasley, A., Simard, E.P., McQuillan, G.M., Kuhnert, W.L., Alter, M.J., 2006. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine 144, 705-714. (Pubitemid 46780630)
3. Batts, K.P., Ludwig, J., 1995. Chronic hepatitis. An update on terminology and reporting. The American Journal of Surgical Pathology 19, 1409-1417.
4. Bedossa, P., Poynard, T., 1996. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24, 289-293. (Pubitemid 26260021)
5. Borchers, A.T., Sakai, S., Henderson, G.L., Harkey, M.R., Keen, C.L., Stern, J.S., Terasawa, K., Gershwin, M.E., 2000. Shosaiko-to and other Kampo (Japanese herbal) medicines: a review of their immunomodulatory activities. Journal of Ethnopharmacology 73, 1-13.
6. Castera, L., 2009. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. Journal of Viral Hepatitis 16, 300-314.
7. Chen, M.H., Chen, J.C., Tsai, C.C., Wang, W.C., Chang, D.C., Tu, D.G., Hsieh, H.Y., 2005. The role of TGF-beta 1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat's bile duct ligated model. Journal of Ethnopharmacology 97, 7-13.
8. Chen, F.P., Chen, F.J., Jong, M.S., Tsai, H.L., Wang, J.R., Hwang, S.J., 2009. Modern use of Chinese herbal formulae from Shang-Han Lun. Chinese Medical Journal (England) 122, 1889-1894.
9. Davis, G.L., Krawczynski, K., Szabo, G., 2007. Hepatitis C virus infection-pathobiology and implications for new therapeutic options. Digestive Diseases and Sciences 52, 857-875. (Pubitemid 46481266)
10. Desmet, V.J., Gerber, M., Hoofnagle, J.H., Manns, M., Scheuer, P.J., 1994. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19, 1513-1520. (Pubitemid 24166476)
11. Fried, M.W., Shiffman, M.L., Reddy, K.R., Smith, C., Marinos, G., Goncales Jr., F.L., Haussinger, D., Diago, M., Carosi, G., Dhumeaux, D., Craxi, A., Lin, A., Hoffman, J., Yu, J., 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. The New England Journal of Medicine 347, 975-982.
12. Gibo, Y., Nakamura, Y., Takahashi, N., et al., 1994. Clinical study of sho-saiko-to therapy for Japanese patients with chronic hepatitis C (CH-C). Progressos da medicina 14, 3.
13. Hadziyannis, S.J., Sette Jr., H., Morgan, T.R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer Jr., H., Bernstein, D., Rizzetto, M., Zeuzem, S., Pockros, P.J., Lin, A., Ackrill, A.M., 2004. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Annals of Internal Medicine 140, 346-355.
14. Hirayama, C., Okumura, M., Tanikawa, K., Yano, M., Mizuta, M., Ogawa, N., 1989. A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis. Gastroenterologia Japonica 24, 715-719. (Pubitemid 20019324)
15. Huang, X.X., Yamashiki, M., Nakatani, K., Nobori, T., Mase, A., 2001. Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system. Journal of Clinical Laboratory Analysis 15, 199-209. (Pubitemid 32642741)
16. Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R.N., et al., 1995. Histological grading and staging of chronic hepatitis. Journal of Hepatology 22, 696-699.
17. Kang, H., Choi, T.W., Ahn, K.S., Lee, J.Y., Ham, I.H., Choi, H.Y., Shim, E.S., Sohn, N.W., 2009. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells. Journal of Ethnopharmacology 123, 6-14.
18. Katou, K., Mori, K., 1999. Autoimmune hepatitis with drug-induced pneumonia due to Sho-saiko-to. Nihon Kokyuki Gakkai Zasshi 37, 641-646.
19. Kayano, K., Sakaida, I., Uchida, K., Okita, K., 1998. Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells. Journal of Hepatology 29, 642-649. (Pubitemid 28484955)
20. Kim, W.R., 2002. The burden of hepatitis C in the United States. Hepatology 36, S30-S34. (Pubitemid 35253461)
21. Kitade, Y., Watanabe, S., Masaki, T., Nishioka, M., Nishino, H., 2002. Inhibition of liver fibrosis in LEC rats by a carotenoid, lycopene, or a herbal medicine, Sho-saiko-to. Hepatology Research 22, 196-205. (Pubitemid 34257592)
22. Kleiner, D.E., 2005. The liver biopsy in chronic hepatitis C: a view from the other side of the microscope. Seminars in Liver Disease 25, 52-64. (Pubitemid 40322350)
23. Kusunose, M., Qiu, B., Cui, T., Hamada, A., Yoshioka, S., Ono, M., Miyamura, M., Kyotani, S., Nishioka, Y., 2002. Effect of Sho-saiko-to extract on hepatic inflammation and fibrosis in dimethylnitrosamine induced liver injury rats. Biological and Pharmaceutical Bulletin 25, 1417-1421. (Pubitemid 39663157)
24. Maheshwari, A., Ray, S., Thuluvath, P.J., 2008. Acute hepatitis C. Lancet 372, 321-332. (Pubitemid 352020441)
25. Manns, M.P., McHutchison, J.G., Gordon, S.C., Rustgi, V.K., Shiffman, M., Reindollar, R., Goodman, Z.D., Koury, K., Ling, M., Albrecht, J.K., 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358, 958-965. (Pubitemid 32913521)
26. Manns, M.P., Wedemeyer, H., Cornberg, M., 2006. Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55, 1350-1359. (Pubitemid 44277369)
27. Nainan, O.V., Alter, M.J., Kruszon-Moran, D., Gao, F.X., Xia, G., McQuillan, G., Margolis, H.S., 2006. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States. Gastroenterology 131, 478-484. (Pubitemid 44142463)
28. Nose, M., Terawaki, K., Iwahashi, N., Oguri, K., Ogihara, Y., 2002. Comparative study of the high molecular mass fraction and low molecular mass fraction of Sho-saiko-to in a murine immunologically induced liver injury model. Biological and Pharmaceutical Bulletin 25, 64-67.
29. Ohtake, N., Nakai, Y., Yamamoto, M., Sakakibara, I., Takeda, S., Amagaya, S., Aburada, M., 2004. Separation and isolation methods for analysis of the active principles of Sho-saiko-to (SST) oriental medicine. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 812, 135-148. (Pubitemid 39535406)
30. Ohtake, N., Yamamoto, M., Takeda, S., Aburada, M., Ishige, A., Watanabe, K., Inoue, M., 2005. The herbal medicine Sho-saiko-to selectively inhibits CD8+ T-cell proliferation. European Journal of Pharmacology 507, 301-310. (Pubitemid 40126867)
31. Oka, H., Yamamoto, S., Kuroki, T., Harihara, S., Marumo, T., Kim, S.R., Monna, T., Kobayashi, K., Tango, T., 1995. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 76, 743-749.
32. Pawlotsky, J.M., Chevaliez, S., McHutchison, J.G., 2007. The hepatitis C virus life cycle as a target for new antiviral therapies. Gastroenterology 132, 1979-1998. (Pubitemid 46695724)
33. Pereira, A.A., Jacobson, I.M., 2009. New and experimental therapies for HCV. Nature Reviews Gastroenterology and Hepatology 6, 403-411.
34. Poynard, T., Yuen, M.F., Ratziu, V., Lai, C.L., 2003. Viral hepatitis C. Lancet 362, 2095-2100. (Pubitemid 38035201)
35. Sakaida, I., Hironaka, K., Kimura, T., Terai, S., Yamasaki, T., Okita, K., 2004. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell. Life Science 74, 2251-2263. (Pubitemid 38249546)
36. Sato, A., Toyoshima, M., Kondo, A., Ohta, K., Sato, H., Ohsumi, A., 1997. [Pneumonitis induced by the herbal medicine Sho-saiko-to in Japan]. Nihon Kyobu Shikkan Gakkai Zasshi 35, 391-395.
37. Shimizu, I., 2000. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. Journal of Gastroenterology and Hepatology 15, D84-D90. (Pubitemid 30190730)
38. Shimizu, I., 2001. Antifibrogenic therapies in chronic HCV infection. Current Drug Targets Infectious Disorders 1, 227-240.
39. Shimizu, I., Ma, Y.R., Mizobuchi, Y., Liu, F., Miura, T., Nakai, Y., Yasuda, M., Shiba, M., Horie, T., Amagaya, S., Kawada, N., Hori, H., Ito, S., 1999. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29, 149-160. (Pubitemid 29023997)
40. Stickel, F., Brinkhaus, B., Krahmer, N., Seitz, H.K., Hahn, E.G., Schuppan, D., 2002. Antifibrotic properties of botanicals in chronic liver disease. Hepatogastroenterology 49, 1102-1108. (Pubitemid 34809798)
41. Tajiri, H., Kozaiwa, K., Ozaki, Y., Miki, K., Shimuzu, K., Okada, S., 1991. Effect of sho-saiko-to(xiao-chai-hu-tang) on HBeAg clearance in children with chronic hepatitis B virus infection and with sustained liver disease. The American Journal of Chinese Medicine 19, 121-129.
42. Williams, R., 2006. Global challenges in liver disease. Hepatology 44, 521-526. (Pubitemid 44433707)
43. Yamashiki, M., Nishimura, A., Huang, X.X., Nobori, T., Sakaguchi, S., Suzuki, H., 1999. Effects of the Japanese herbal medicine "Sho-saiko- to" (TJ-9) on interleukin-12 production in patients with HCV-positive liver cirrhosis. Developmental Immunology 7, 17-22.